NCT01343914已完成不适用
Retrospective Study to Determinate the Clinical Phenotype of Patients With Non Squamous NSCLC Treated With First Line Bevacizumab-based Therapy That Reached a Long PFS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 118
- 主要终点
- Progression-free survival (>9 months) according to clinical phenotype
研究概览
简要总结
This retrospective observational study will analyse demographic, clinical and treatment-related data of patients with non-squamous non-small cell lung cancer (NSCLC) who had reached >/= 9 months of progression-free survival after Avastin (bevacizumab)-based first-line therapy. Data will be collected for approximately 9 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, >/= 18 years of age
- •Non-squamous non-small cell lung cancer (NSCLC) treated with first-line Avastin-based therapy
- •Progression-free survival of >/= 9 months reached
排除标准
- 未提供
结局指标
主要结局
Progression-free survival (>9 months) according to clinical phenotype
时间窗: approximately 9 months
次要结局
- Safety: Incidence of adverse events(approximately 9 months)
- Overall survival(approximately 9 months)
研究者
相似试验
已完成
不适用
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient ProgramChronic Lymphocytic LeukemiaNCT02582320Gruppo Italiano Malattie EMatologiche dell'Adulto264
Unknown
不适用
A Retrospective Study Investigating the Factors Related to Non-tuberculous Mycobacterial Pulmonary Disease in Hong KongNon-Tuberculous Mycobacterial PneumoniaNCT04538898Chinese University of Hong Kong200
已完成
不适用
Study With DapagliflozinDiabetes Mellitus Type 2NCT02971618AstraZeneca929
已完成
不适用
Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2ELGMD2ENCT04509609Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico33
已完成
不适用
Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment PatternAsthmaNCT03963141AstraZeneca40,541